Drug Shortage Report for CATHFLO

Last updated on 2025-01-30 History
Report ID 247639
Drug Identification Number 02245859
Brand name CATHFLO
Common or Proper name ALTEPLASE
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) ALTEPLASE
Strength(s) 2MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INSTILLATION INSTILLATION
Packaging size 2MG VIAL, PACK OF 10 VIALS
ATC code B01AD
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2025-03-03
Actual start date
Estimated end date 2025-04-16
Actual end date
Shortage status Anticipated shortage
Updated date 2025-01-30
Company comments A supply allocation of Cathflo is now in effect due to administrative site changes. We are currently working to resolve these issues so that we can resume normal supply distribution as soon as possible. If you require urgent assistance regarding Cathflo supply please contact Order and Distribution Management: mississauga.order_mgmt@roche.com or through the CPDN portal.
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-01-30 French Compare
v5 2025-01-30 English Compare
v4 2025-01-13 French Compare
v3 2025-01-13 French Compare
v2 2025-01-13 English Compare
v1 2025-01-13 English Compare

Showing 1 to 6 of 6